Member Info for mathsprof

How do you get big red print in an RNS?

Adam
How many parties make up a normal deal?
At least 2. Here my take is that there may be 6. 6 parties to a single deal - they've all to agree the terms.
Who they are we can only guess - but remember Valiseek already has more than 1 party involved.
I think its only one set of negotiations - just with many parties.
Would explain the everlasting wait, though.

By my calculations 25 posts have been removed today - that is if we believe the post counter on the top of the page. The trouble is that often a whole thread goes even though there may be some decent posts amongst it.

A bit excessive.

They're probably not. Two of the parties are Valirx and Tangent. Satu the third...?? Then maybe there's regulators in 2 territories???? Oh yes, and that leaves one company. hurrah!!

Rightback - They're the same trade - one + one -.

So it cost him/her £140 to buy and sell.

My calculations are that the 17.86% consists of the shares owned by Calculus Capital (12.89%) and the directors etc (4.97%). But then there's Hygea (3.42%) L&G Investment (4.68%) and City Financial (5.62%). Why aren't they counted? They look like IIs to me, rather than holdings of PIs.

Is there a difference in Calculus (I like the name!!) and the others? Any thoughts? What makes a fund and II?

Any one else noticed? Today's late bigs are exactly half the size of yesterday's. So must all be done by same trader. But what's the real story behind what looks like two rollovers?

It was a sell at 1.85p so wont affect the chart - quote at time remained at 1.8-2.0p until tick up to 1.9-2.2p later.

No Freddie. The previous trade @ 1.93p was a sell and prompted a drop in bid to 1.85p for the 0925 one. Doesn't take much for MMs to widen the spread and some sold at lower price too. Hard luck them!

Actually it went down very well. There was no adverse SP reaction to what is essentially a non-news event. Perhaps that was because there was no false expectation beforehand (as there was eg at Scancell today)

If you're more with it than me, you'll realise I've got bid and offer the wrong way round!

Its the way MMs always (well the good majority of the time) advertise the spreads on small AIM stocks. Usually the quoted prices move in fixed increments, eg here its now 0.1p - in the past we only moved in quarters.
So a move up from 1.8-2.0 might be 1.9-2.0 or 1.8-2.1 etc. If we were to see trades of 2.000p happening, the next stage might be that you cant get an online quote, or the bid is pushed up to the next level.
Unusually the actual offer today has been over 1.9p, but there is a reluctance to narrow the spread quoted. Maybe they're actually thinking in 0.2p increments when volumes are lowish.
I'm guessing a bit, but never expect to see a spread as accurate as 1.93-1.98p on this on any similar stock!!!

The placing shares make up 14.4% of the total. We have seen a 4.2% trade and then the beast's 1.25%.

Will we get any holdings RNSs before the w/e? I don't think the flipped shares will need to be declared, so any RNS could be of interest.

I wasn't suggesting no-one is interested. It just may be that Valiseek can't agree the terms or the scientific evidence for the compound is thought to be underwhelming.

Much more likely I think, is that nothing can be announced/ finally agreed until regulators etc are done.

My theory is that the placing was necessary and independent of any negotiations for 401.

It is possible that a 401 JV won't bring any immediate cash to Valirx. Remember that it's Valiseek that will be looking for a deal, and as such may be a JV which mainly involves issuing more shares in Valiseek in exchange for £20m to do the trial. How this might affect the SP of Val would depend on the percentage of Valiseek offered. The JV model would then be similar to the original JV deal involving Tangent and Valirx. Also, any cash in the deal would belong to Valiseek, not Valirx directly. Would it be distributed to partners in Valiseek immediately? No idea.

Conclusion. The timing of the placing gives us no new clue as to how soon a deal for 401 might be concluded/announced. There's still a possibility that no-one is interested on the terms currently being offered.

They didn't take too long to resubmit the paperwork with the tweaks required, then. Let's hope the signing off is now quick.

https://clinicaltrials.gov/ct2/show/results/NCT02875340?term=VAL401&draw=1&rank=1&view=results

I can now sell at 1.77p. I suppose some MMs still have little stock....

Just got a sell quote st 1.76p - but can still buy at 1.75p. What's going on?

22.5m sold!!!